首页> 外文期刊>Modern Pathology >Methylene blue injection into the rectal artery as a simple method to improve lymph node harvest in rectal cancer
【24h】

Methylene blue injection into the rectal artery as a simple method to improve lymph node harvest in rectal cancer

机译:向直肠动脉注射亚甲蓝作为改善直肠癌淋巴结收集的简单方法

获取原文
           

摘要

Adequate lymph node assessment in colorectal cancer is crucial for prognosis estimation and further therapy stratification. However, there is still an ongoing debate on required minimum lymph node numbers and the necessity of advanced techniques such as immunohistochemistry or PCR. It has been proven in several studies that lymph node harvest is often inadequate under routine analysis. Lymph nodes smaller than 5mm are especially concerning as they can carry the majority of metastases. These small, but affected lymph nodes may escape detection in routine analysis. Therefore, fat-clearing protocols and sentinel techniques have been developed to improve accuracy of lymph node staging. We describe a novel and simple method of ex vivo methylene blue injection into the superior rectal artery of rectal cancer specimens, which highlights lymph nodes and makes them easy to detect during manual dissection. Initially, this method was developed for proving accuracy of total mesorectal excision. We performed a retrospective study comparing lymph node recovery of 12 methylene blue stained and an equal number of unstained cases. Lymph node recovery differed significantly with average lymph node numbers of 277 and 144 (P<0.001) for the methylene blue and the unstained group, respectively. The largest difference was found in size groups between 1 and 4mm causing a shift in size distribution toward smaller nodes. Metastases were confirmed in 21 and 19 lymph nodes occurring in five and four cases, respectively. Hence, we conclude that methylene blue injection technique improves accuracy of lymph node staging by heightening the lymph node harvest in rectal resections. In our experience, it is a very simple time and cost effective method that can be easily established under routine circumstances.
机译:大肠癌中充分的淋巴结评估对于评估预后和进一步的治疗分层至关重要。然而,关于所需的最小淋巴结数目和是否需要先进技术(例如免疫组织化学或PCR)的争论仍在进行。在几项研究中已经证明,常规分析下淋巴结收集常常不足。小于5mm的淋巴结尤为重要,因为它们可以携带大部分转移灶。这些小的但受影响的淋巴结可能无法进行常规分析。因此,已经开发出脂肪清除方案和哨兵技术以提高淋巴结分期的准确性。我们描述了一种新的简单方法,将亚甲基蓝离体注射到直肠癌标本的直肠上动脉中,该方法突出了淋巴结并使其在手动解剖时易于检测。最初,开发这种方法是为了证明全直肠系膜切除术的准确性。我们进行了一项回顾性研究,比较了12个亚甲蓝染色和相同数量的未染色病例的淋巴结恢复情况。亚甲基蓝组和未染色组的淋巴结恢复显着不同,平均淋巴结数目分别为277和144(P <0.001)。在1至4mm的尺寸组中发现最大的差异,导致尺寸分布向较小的节点移动。在分别发生在5例和4例中的21例和19例淋巴结中确认了转移。因此,我们得出结论,亚甲基蓝注射技术通过提高直肠切除术中淋巴结的收获来提高淋巴结分期的准确性。根据我们的经验,这是一种非常简单的时间和成本有效的方法,可以在常规情况下轻松建立。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号